No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Why Appen, Mayne Pharma, Playside, and PYC Shares Are Storming Higher
Mayne Pharma Reiterates H2 FY24 Outlook in Wake of Change Healthcare Cyberattack
Cyberattack Only a Temporary Setback for Mayne Pharma -- Market Talk
Mayne Pharma Price Target Cut 4% to A$7.09/Share by Wilsons
Mayne Pharma Group Limited's (ASX:MYX) Largest Shareholders Are Individual Investors With 38% Ownership, Institutions Own 33%
Mayne Pharma Group's Nextstellis Oral Contraceptive Receives Two Additional US Patents
No Data